Evidence map›Paper›PMID 28964912›Full record

ArticleBehavioural brain research2018

Functional coding variation in the presynaptic dopamine transporter associated with neuropsychiatric disorders drives enhanced motivation and context-dependent impulsivity in mice.

Gwynne L Davis, Adele Stewart, Gregg D Stanwood, Raajaram Gowrishankar, Maureen K Hahn, Randy D Blakely

Abstract read
In one paragraph

Article in Behavioural brain research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Vitamin A deficiency induces sex-specific reward processing alterations through a dysregulation of the mesolimbic dopamine transmission in mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review of rodent models of attention deficit hyperactivity disorder.Neuroscience and biobehavioral reviews · 2022
    Review
  10. Article
  11. Review
  12. Dysregulation of brain dopamine systems in major depressive disorder.Experimental biology and medicine (Maywood, N.J.) · 2021
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Region-Specific Regulation of Presynaptic Dopamine Homeostasis by DThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Gwynne L DavisDepartment of Pharmacology, Vanderbilt University, 2220 Pierce Ave, Nashville, TN 37232, United States; Department of Biomedical Science, Charles E. Schmidt College of Medicine, United States. Electronic address: davisg@health.fau.edu.
Adele StewartDepartment of Pharmacology, Vanderbilt University, 2220 Pierce Ave, Nashville, TN 37232, United States; Department of Biomedical Science, Charles E. Schmidt College of Medicine, United States; Brain Institute, Florida Atlantic University, 5353 Parkside Drive, Jupiter, FL 33458, United States. Electronic address: stewarta@health.fau.edu.
Gregg D StanwoodBiomedical Sciences, Florida State University College of Medicine, 1115 West Call Street, Tallahassee, FL, 32306, United States. Electronic address: gregg.stanwood@med.fsu.edu.
Raajaram GowrishankarDepartment of Pharmacology, Vanderbilt University, 2220 Pierce Ave, Nashville, TN 37232, United States; Department of Biomedical Science, Charles E. Schmidt College of Medicine, United States. Electronic address: rgowrishankar@health.fau.edu.
Maureen K HahnDepartment of Pharmacology, Vanderbilt University, 2220 Pierce Ave, Nashville, TN 37232, United States; Department of Biomedical Science, Charles E. Schmidt College of Medicine, United States; Brain Institute, Florida Atlantic University, 5353 Parkside Drive, Jupiter, FL 33458, United States. Electronic address: hahnm@health.fau.edu.
Randy D BlakelyDepartment of Pharmacology, Vanderbilt University, 2220 Pierce Ave, Nashville, TN 37232, United States; Department of Biomedical Science, Charles E. Schmidt College of Medicine, United States; Brain Institute, Florida Atlantic University, 5353 Parkside Drive, Jupiter, FL 33458, United States. Electronic address: rblakely@fau.edu.
Vanderbilt University · USFlorida Atlantic University · USFlorida State University · US

Funding

Program in NeurogenomicsT32MH065215 · NIMH · VANDERBILT UNIVERSITY · PI ROGER J COLBRAN · 2002 to 2026
$6.4M
KNOCK-IN MOUSE MODEL OF DOPAMINE DYSFUNCTION UNDERLYING TRAITS OF ADHDR01MH105094 · NIMH · VANDERBILT UNIVERSITY · PI BLAKELY, RANDY D. · 2014 to 2018
$1.9M
In Vivo Modeling of Heritable Dopamine Transporter Dysfunction Associated with Neuropsychiatric DisordersF31MH107132 · NIMH · VANDERBILT UNIVERSITY · PI DAVIS, GWYNNE LANE · 2015 to 2016
$56k
NIMH NIH HHS F31 MH107132NIMH NIH HHS R01 MH105094NIMH NIH HHS T32 MH065215
6 · The paper itself

Abstract

Recent genetic analyses have provided evidence that clinical commonalities associated with different psychiatric diagnoses often have shared mechanistic underpinnings. The development of animal models expressing functional genetic variation attributed to multiple disorders offers a salient opportunity to capture molecular, circuit and behavioral alterations underlying this hypothesis. In keeping with studies suggesting dopaminergic contributions to attention-deficit hyperactivity disorder (ADHD), bipolar disorder (BPD) and autism spectrum disorder (ASD), subjects with these diagnoses have been found to express a rare, functional coding substitution in the dopamine (DA) transporter (DAT), Ala559Val. We developed DAT Val559 knock-in mice as a construct valid model of dopaminergic alterations that drive multiple clinical phenotypes, and here evaluate the impact of lifelong expression of the variant on impulsivity and motivation utilizing the 5- choice serial reaction time task (5-CSRTT) and Go/NoGo as well as tests of time estimation (peak interval analysis), reward salience (sucrose preference), and motivation (progressive ratio test). Our findings indicate that the DAT Val559 variant induces impulsivity behaviors that are dependent upon the reward context, with increased impulsive action observed when mice are required to delay responding for a reward, whereas mice are able to withhold responding if there is a probability of reward for a correct rejection. Utilizing peak interval and progressive ratio tests, we provide evidence that impulsivity is likely driven by an enhanced motivational phenotype that also may drive faster task acquisition in operant tasks. These data provide critical validation that DAT, and more generally, DA signaling perturbations can drive impulsivity that can manifest in specific contexts and not others, and may rely on motivational alterations, which may also drive increased maladaptive reward seeking.

Indexed as

AnimalsChoice BehaviorDisease Models, AnimalDopamine Plasma Membrane Transport ProteinsFood PreferencesImpulsive BehaviorMaleMental DisordersMiceMice, Inbred C57BLMice, TransgenicMotivationMutationReinforcement, PsychologySucroseSweetening AgentsDopamine Plasma Membrane Transport ProteinsSucroseSweetening AgentsValineAttention-deficit hyperactivity disorderDopamine transporterImpulsivityInstrumental learningMotivationTransgenic model

Identifiers

PMID28964912
PMCPMC5645257
OpenAlexW2759556048

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.